These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 28450298)
1. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing. Wang X; Peter K Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298 [TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles. Vazquez-Prada KX; Lam J; Kamato D; Xu ZP; Little PJ; Ta HT Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):601-613. PubMed ID: 33356385 [TBL] [Abstract][Full Text] [Related]
3. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque. MacAskill MG; Newby DE; Tavares AAS Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100 [TBL] [Abstract][Full Text] [Related]
4. MRI, the technology for imaging of thrombi and inflammation. von Zur Muhlen C; Bode C Hamostaseologie; 2015; 35(3):252-62. PubMed ID: 25634650 [TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations? Brammen L; Steiner S; Berent R; Sinzinger H Vasa; 2016; 45(2):125-32. PubMed ID: 27058798 [TBL] [Abstract][Full Text] [Related]
6. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - Novel insights and future directions in diagnosis and therapy. Hartley A; Haskard D; Khamis R Trends Cardiovasc Med; 2019 Jan; 29(1):22-26. PubMed ID: 29934015 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis. Qiao R; Huang X; Qin Y; Li Y; Davis TP; Hagemeyer CE; Gao M Nanoscale; 2020 Apr; 12(15):8040-8064. PubMed ID: 32239038 [TBL] [Abstract][Full Text] [Related]
13. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques]. Zhao ZM; Qin SC Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253 [TBL] [Abstract][Full Text] [Related]
14. Imaging of atherosclerosis: can molecular imaging do more? Lairez O; Fayad ZA Arch Cardiovasc Dis; 2013 Nov; 106(11):551-3. PubMed ID: 23927996 [No Abstract] [Full Text] [Related]
15. Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective. Krishnan S; Otaki Y; Doris M; Slipczuk L; Arnson Y; Rubeaux M; Dey D; Slomka P; Berman DS; Tamarappoo B J Nucl Med; 2017 Mar; 58(3):359-364. PubMed ID: 28183988 [TBL] [Abstract][Full Text] [Related]
16. Molecular imaging of arterial and venous thrombosis. Wang X; Ziegler M; McFadyen JD; Peter K Br J Pharmacol; 2021 Nov; 178(21):4246-4269. PubMed ID: 34296431 [TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models. Gargiulo S; Gramanzini M; Mancini M Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618031 [TBL] [Abstract][Full Text] [Related]
18. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's. den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907 [TBL] [Abstract][Full Text] [Related]